Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

More about this publication

Nature medicine
  • Publication date 04-08-2025

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.